UAB "Swixx Biopharma"

Make sure your business meets the highest market standards. ebm certificate 2024

Check company

Okredo company details

Legal status

Active

Company ID

303481894

VAT code

LT100009238214

From 19/03/2015

Incorporation date

04/12/2014

Company's manager/representative

Piret Tuul, Director General

Share capital

2,896.00 EUR

Activity

Market research and public opinion polling

Contacts

Company registration address

Vilnius, Bokšto g. 1-3, LT-01126Check the map

Website

High

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Get a loan for your business

Fill out the application 100 000 €

Apply for a loan

Number of employees

-3 *

* during past year

Average wage

5,746.01 €

5,311.62 €

7,980.07 €

+378.56 € *

* during past year

Debts

0.00 €

Debt for business:Unlock

0 € *

* during past year

2024

-1 %

Turnover

5,753,408 €

Credit report

Data sources

Business linkages

Linkages

Monitoring

Changes during the year

Similar companies

Company's value

explore Okredo data

Credit limit

Estimated

UAB "Swixx Biopharma" related persons

Manager

(4)

LR persons: 1,Foreign persons: 3

Historical managers: 6

Board

(0)

Historical board members: 0

Shareholder

(1)

Foreign companies: 1

Historical shareholders: 1

Business linkages

Price: €17.99
Premium users: 1.00 credit

Sanctions search

Price: €17.99
Premium users: 1.00 credit

Order report

Name, Surname	Title	Start date	End date	Linkages
Piret Tuul	Director General	10/07/2024	-	29
RIMA JANKOVSKA	Procuration	04/12/2024	-	11
Laur Saar	Procuration	04/12/2024	-	12
DEZSO MARTHA	Procuration	04/12/2024	-	0

UAB "Swixx Biopharma" financial ratios

EBITDA margin (%)

explore Okredo data

EBIT margin (%)

explore Okredo data

Financial statement report

Price: €9.90
Premium users: 1.00 credit

Indicator
Turnover (€)
Sales per employee (€)
Profit before tax (€)
Net Profit (€)
Profit per employee (€)
Total profitability (%)
Net profitability (%)
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirement
Debt-to-equity ratio
EBITDA margin (%)
EBITDA (€)
EBIT margin (%)
EBIT (€)

2022
5,166,407
127,786
301,363
264,118
6,533
84.06
5.11
602,793
580,246
96,663
1,035,103

2023
5,786,464
138,797
381,645
302,989
7,268
84.57
5.24
905,783
769,783
109,242
1,466,233

2024
5,753,408
130,908
325,690
273,862
6,231
83.68
4.76
1,179,645
786,347
82,301
1,811,460

explore Okredo data

2024

Turnover (€)

5,753,408 €-1 % *

Sales per employee (€)

130,908 €-6 % *

Profit before tax (€)

325,690 €-15 % *

Net Profit (€)

273,862 €-10 % *

Profit per employee (€)

6,231 €-14 % *

Total profitability (%)

83.68 %-1.05 % *

Net profitability (%)

4.76 %-9.16 % *

Equity (€)

1,179,645 €30 % *

Amounts Payable And Liabilities (€)

786,347 €2 % *

Non-current Assets (€)

82,301 €-25 % *

CurrentAssets (€)

1,811,460 €24 % *

*over the last year starting selected period

Credit history

No. of unpaid debts

explore Okredo data

Amount of unpaid debts

explore Okredo data

Credit report

Price: €35.99
Premium users: 1.00 credit

Company has debt ?

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debts payment history

Creditor/Data source	Debt amount	Debt date / Payment date	Debt type
-	-	-	-

Tax debts

Sodra debt

STI debt

Courts

Defendant

(0)

No information (company as defendant)Within last 2 years

Plaintiff

(0)

No information (company as plaintiff)Within last 2 years

3rd party

(0)

No information (company as third-party)Within last 2 years

Cases (Company as defendant)

Case No./date	Process parties	Case/Court ruling	Court	No. of court hearings	More
-	-	-	-	-	-

Cases (Company as plaintiff)

Case No./date	Process parties	Case/Court ruling	Court	No. of court hearings	More
-	-	-	-	-	-

Cases (Company as third party)

Case No./date	Process parties	Case/Court ruling	Court	No. of court hearings	More
-	-	-	-	-	-

ESG data

Energy performance of the company's head office building

Energy efficiency

AddressVilnius, Bokšto g. 1-3, LT-01126

Certificate No.KG-0488-15147

Date of issue21/01/2022

Valid till21/01/2032

Heated area54.35 m²

Heat sourcenenustatyta

Energy consumption

0 kWh/m²/metai

Co2 emission

Energy consumption for heating

Building function

Kiti gyvenamieji pastatai (namai)

Energy effiency class

Vehicles

Company's eco score according CO² of vehicle fleet

<120

120 - 140

140 - 155

155 - 170

170 - 190

190 - 255

255+

Not determined

Maximum environmental friendliness

Lowest environmental friendliness

Vehicles

CLASS

AMOUNT

(<120)

(120 - 140)

(140 - 155)

(155 - 170)

(170 - 190)

(190 - 255)

(255+)

(Not determined)

Total

Eco score	Brand, model	Category	Engine capacity	Fuel
0	SKODA ENYAQ 60First registration: 10/11/2023	Passenger car	-	Electricity
102	VOLKSWAGEN. VW PASSATFirst registration: 06/11/2020	Passenger car	1,968.00 cm³	Diesel
110	SKODA OCTAVIAFirst registration: 14/01/2020	Passenger car	1,968.00 cm³	Diesel
116	VOLKSWAGEN. VW GOLFFirst registration: 21/05/2020	Passenger car	1,498.00 cm³	Petrol
117	VOLKSWAGEN. VW PASSATFirst registration: 17/08/2020	Passenger car	1,498.00 cm³	Petrol

Trademarks

Company registered trademarks

Trademark view	Trademark	Type	Application No	Registration No	Expire	TM status
	AMICUS Modern Medicines for All	Graphical	2015 1102	73044	05/12/2016	Unknown

Public data

Govermental support

Institution	Support measure
	Subsidies to preserve work places
	Subsidies for downtime in 2020
	ILTE business promotion measures (subsidies, compensations) in 2020
	ILTE business promotion measures (guarantees provided) in 2020
	ILTE business promotion measures (guarantees provided) in 2021

explore Okredo data

Public negative information

Institution	Support measure
	Redundancy of employees group (number of employees notified, date of announcement)
	Tax inspectorate information on payments in cash
	Public procurement office information on unreliable suppliers
	Public procurement office information on those that supplied false data
	Public procurement office information on possible disqualification from public procurement procedures

explore Okredo data

Public data

Institution	Support measure
	Data from the B2Lithuania database of exporters
	The biggest taxpayers in 2021
	Top taxpayers in 2021 excluding excise duties and VAT.
	Top personal income tax payers in 2021
	Top taxpayers for corporate income tax in 2021

explore Okredo data

Licenses

The company has no records of any licenses', permits, certificates, or other licensing documents issued.

Public procurement

No. of won tenders

1* during past year

Total value of contracts

14,000 €

Number of announced tenders

0* during past year

Total value of contracts

0 €

Won tenders

Date	Procurer/contractor	Amount	Project
18/09/2024	Lietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos	14,000 €	Sutartis dėl genetinių tyrimų/ diagnostinių tyrimų apmokėjimo sutartis

Announced tenders

Date	Procurer/contractor	Amount	Project
-	-	-	-

Archive of articles

Data source	Article	Date
-	-	-

BNS News

explore Okredo data

Similar companies

Company's name	Activity	Legal status	Incorporation date	Turnover	No. of employees
Viatris UAB Vilnius, Žalgirio g. 90-100, LT-09303, 303399098	Market research and public opinion polling	Active	24/09/2014	2-5 M € +16.34 %	21 -2
AbbVie UAB Vilnius, Ukmergės g. 120-2, LT-08126, 302679058	Market research and public opinion polling	Active	21/10/2011	5-10 M € -1.80 %	41 +2
UAB "ASTRAZENECA LIETUVA" Vilnius, Spaudos g. 6-1, LT-05132, 300089799	Market research and public opinion polling	Active	18/02/2005	5-10 M € +33.18 %	60 +9
UAB "WorldOne" Vilnius, Lvivo g. 25-104, LT-09320, 111797388	Market research and public opinion polling	Active	26/02/2003	2-5 M € -7.47 %	45 -3
TNS LT, UAB Vilnius, V. Mykolaičio-Putino g. 10-44, LT-03155, 124499452	Market research and public opinion polling	Active	09/07/1998	2-5 M € -25.31 %	59 -8

Description

About UAB "Swixx Biopharma"

UAB "Swixx Biopharma" was established in 04/12/2014, its legal status according to data of Registry of Legal Entities is Active.
Main activity of the company according NACE2 classification – Market research and public opinion polling, 73.20.00. Company is owned by 1 shareholder. Company's representation right – The rule of quantitative representation.
In 2024 UAB "Swixx Biopharma" turnover was 5,753,408 EUR, gross profit 273,862 EUR. According to SODRA company has 41 employees. UAB "Swixx Biopharma" is registered at – Vilnius, Bokšto g. 1-3, LT-01126.

All data about UAB "Swixx Biopharma" is up to date and consistent with the primary data source.